Excluding the impact of AEs led to a QALY difference of 0.031 (0.660 vs 0.629).
Stimulant plus non-stimulant, guanfacine extended release (GXR) 
Stimulant
QALYs (Quality Adjusted Life Year) excluding impact of AEs